Treatment variation in early breast cancer in the UK.
Journal article
Dodwell D. et al, (2020), BMJ, 371
Surgery of the primary tumour in women with metastatic breast cancer at diagnosis in England and Wales – how do treatment rates vary at an individual and regional level?
Journal article
Miller K. et al, (2020), European Journal of Cancer, 138, S116 - S117
Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study.
Journal article
Mannu GS. et al, (2020), BMJ, 369
Initiation of adjuvant chemotherapy and trastuzumab for human epidermal growth receptor 2-positive early invasive breast cancer in a population-based cohort study of older women in England
Journal article
DODWELL D., (2020), Journal of Geriatric Oncology
Addressing frailty in patients with breast cancer: A review of the literature
Journal article
Jauhari Y. et al, (2020), European Journal of Surgical Oncology, 46, 24 - 32
Lapatinib plus Capecitabine versus Trastuzumab plus Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer with Central Nervous System Metastases for Patients Currently or Previously Treated with Trastuzumab (LANTERN): a Phase II Randomised Trial
Journal article
Seligmann JF. et al, (2020), Clinical Oncology
Immediate and delayed autologous abdominal microvascular flap breast reconstruction in patients receiving adjuvant, neoadjuvant or no radiotherapy: a meta‐analysis of clinical and quality‐of‐life outcomes
Journal article
Khajuria A. et al, (2019), BJS Open
Eligibility for Partial Breast Radiotherapy in England.
Journal article
Taylor CW. et al, (2019), Clin Oncol (R Coll Radiol)
Endocrine therapy in the years following a diagnosis of breast cancer: A proof of concept study using the primary care prescription database linked to cancer registration data.
Journal article
Emanuel G. et al, (2019), Cancer Epidemiol, 61, 185 - 189
International Variation in Criteria for Internal Mammary Chain Radiotherapy.
Journal article
Duane FK. et al, (2019), Clin Oncol (R Coll Radiol)
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.
Journal article
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2019), Lancet, 393, 1440 - 1452
Adjuvant treatment for breast cancer
Journal article
Flatley MJ. and Dodwell DJ., (2019), Surgery (United Kingdom)
The SMALL Trial: A Big Change for Small Breast Cancers
Journal article
Morgan J. et al, (2019), Clinical Oncology
Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project.
Journal article
Thompson AM. et al, (2018), Eur J Cancer, 101, 210 - 219
Should patients with ductal carcinoma in situ be treated with adjuvant whole breast radiotherapy after breast conservation surgery?
Journal article
Bagenal J. et al, (2018), BMJ, 361
Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ.
Journal article
Maxwell AJ. et al, (2018), Eur J Surg Oncol, 44, 429 - 435
Neoadjuvant chemotherapy for early breast cancer - Author's reply.
Journal article
McGale P. et al, (2018), Lancet Oncol, 19
A longitudinal cohort study to identify risk factors for the development of invasive cancer in unresected DCIS
Journal article
Maxwell AJ. et al, (2018), CANCER RESEARCH, 78
Impact of radiotherapy and endocrine therapy on further events: Final multivariate analysis of a prospective, national cohort study of screen detected ductal carcinoma in situ (DCIS) of the breast
Conference paper
Thompson AM. et al, (2018), CANCER RESEARCH, 78
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.
Journal article
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2018), Lancet Oncol, 19, 27 - 39